NEUROSCIENCES, cilt.20, sa.2, ss.124-130, 2015 (SCI-Expanded)
Objective: To evaluate the therapeutic effects of inhibiting interleukin-1 beta (IL-1 beta) in vivo using Anakinra in an experimental model of spinal cord injury (SCI).